Cynthia L Nichols

Title: Inventor Spotlight: Cynthia L. Nichols

Introduction: Cynthia L. Nichols, a prolific inventor based in Indianapolis, IN, has made significant contributions to the field of pharmaceuticals with 6 patents to her name. Her latest patents showcase her expertise in developing dopamine D-1 antagonists and innovative immunoglobulin conjugates.

Latest Patents:

1. "2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists - D-2-Alkyl(or phenyl)thio-6-n-alkylergolines or .+-.-2-alkyl(or phenyl)thio-4-dialkylaminotetrahydrobenz[c,d]indoles, dopamine D-1 antagonists."

2. "Hydrazone immunoglobulin conjugates - Immunoglobulin conjugates formed by reaction of an antineoplastic indole-dihydroindole vinca alkaloid containing a hydrazine group attached at C-3 or C-4 with an oxidized glycoprotein containing aldehyde groups."

Career Highlights: Cynthia is a valuable member of Eli Lilly and Company, a renowned pharmaceutical company known for its innovative research and development. Through her work at Eli Lilly, Cynthia has demonstrated her commitment to advancing the pharmaceutical industry with groundbreaking inventions.

Collaborations: Cynthia has collaborated with esteemed professionals in the field, including coworkers Bennett C. Laguzza and Edmund C. Kornfeld. These collaborations have further enriched her innovative projects and contributed to the success of her patent applications.

Conclusion: Cynthia L. Nichols's exceptional work in pharmaceutical inventions highlights her as a skilled inventor with a passion for advancing healthcare solutions. Her patents reflect a dedication to creating cutting-edge treatments and pushing the boundaries of pharmaceutical innovation.